HIV Pre-Exposure Prophylaxis Provider Assessment

Pre-Exposure Prophylaxis (PrEP) is an HIV prevention strategy based on a daily pill taken by HIV-negative individuals. PrEP contains two antiretroviral medications-tenofovir and emtricitabine. The brand name for PrEP is Truvada. PrEP is meant to be used in combination with other HIV prevention methods, such as condoms. The Centers for Disease Control and Prevention (CDC) recommends PrEP as an effective method for reducing the risk of HIV infection. PrEP should be considered for those at high risk for contracting HIV. These may include men who have sex with men (MSM), injection drug users, and HIV negative individuals with HIV positive partners. 

If you would like to have an update on PrEP at your clinical site, or if you are providing PrEP and would like your site to be included in a PrEP provider directory that will be posted on the Phila Dept. of Public Health Website, please contact Erika Aaron, at erika.aaron@phila.gov

Question Title

* 1. What is your gender?

Question Title

* 2. What is your age?

Question Title

* 3. How many years have you worked as a health care provider?

Question Title

* 4. Please indicate your credential type below:

Question Title

* 5. Please indicate your practice type:

Question Title

* 6. What type of setting do you work in?

Question Title

* 7. What is your Zip Code?

Question Title

* 8. Number of HIV+ persons cared for ever

Question Title

* 9. Has a patient ever asked you about PrEP?

Question Title

* 10. Have you ever initiated a discussion about PrEP with a patient?

Question Title

* 11. Which of the following statements best applies to you?

Question Title

* 12. If you will not prescribe PrEP, please indicate your reason why:

Question Title

* 13. If you have prescribed PrEP, please indicate the number of patients you've  prescribed it to?

Question Title

* 14. If you have prescribed PrEP, please indicate who you've prescribed to:

Question Title

* 15. If you have had a patient(s) referred to you for PrEP, who was your referral source(s)?

Question Title

* 16. Would you attend a PrEP clinical training (either online or in-person)?

Question Title

* 17. What is your preferred training modality? (Check all that apply)

Question Title

* 18. To what extent do you agree with the following statements?

  Strongly Disagree  Disagree  No Opinion or Uncertain  Agree  StronglyAgree
I am familar with current research on PrEP safety
I am comfortable discussing HIV risk factors with my patients
I can determine if PrEP is indicated for my patients
I know the required labs for PrEP initiation and management 
I am comfortable prescribing PrEP for my patients
I know the resources available to help patients pay for PrEP

Question Title

* 19. Please rank your clinic's ability to provide the following PrEP support

  Yes, we provide this service at our clinic  Maybe, we could provide this service with more training  No, we would need to refer patients elsewhere for this service I don't know
Medication adherence counseling 
HIV risk reduction counseling 
Ensure HIV testing every three months
Ensure other clinical follow-up and monitoring requirements are met for PrEP
Benefits coordination to assist PrEP patients with insurance and patient assistance programs 

T